Challenges in Conducting Studies in Chronic Graft-versus-Host Disease
The lack of standardized criteria for measuring therapeutic response has been a major obstacle to the development of therapeutic trials in chronic graft-versus-host disease (cGvHD). Nevertheless, recent advances have been made in understanding of the biology and pathophysiology of cGvHD, as well as...
Main Authors: | Iskra Pusic, Steven Z. Pavletic |
---|---|
Format: | Article |
Language: | English |
Published: |
Atlantis Press
2019-03-01
|
Series: | Clinical Hematology International |
Subjects: | |
Online Access: | https://www.atlantis-press.com/article/125905876/view |
Similar Items
-
Interleukin-27 Enforces Regulatory T Cell Functions to Prevent Graft-versus-Host Disease
by: Hongnga T. Le, et al.
Published: (2020-02-01) -
The role of chemokines in mediating graft versus host disease (GVHD): opportunities for novel therapeutics
by: Marina Gomes Miranda Castor, et al.
Published: (2012-02-01) -
Editorial: Pathogenesis and Therapy of Graft-versus-Host Disease
by: Brian C. Betts, et al.
Published: (2019-07-01) -
18F-FDG-PET-MRI for the assessment of acute intestinal graft-versus-host-disease (GvHD)
by: Wolfgang Roll, et al.
Published: (2021-09-01) -
Differential MicroRNA Expression Levels in Cutaneous Acute Graft-Versus-Host Disease
by: Sadaf Atarod, et al.
Published: (2018-07-01)